	Is There an Ethically Acceptable Threshold for Live Donor Risk? Michael Abecassis, MD, MBA J. Roscoe Miller Distinguished Professor Departments of Surgery and Microbiology/Immunology Feinberg School of Medicine, Northwestern University; Chief, Division of Organ Transplantation Northwestern Memorial Hospital; Founding Director, Comprehensive Transplant Center Northwestern University Chicago, Illinois
	Multiple Myeloma—New Therapies for an Old Paradigm William I. Bensinger, MD Member, Clinical Research Division Fred Hutchinson Cancer Research Center Professor, University of Washington School of Medicine Director, Autologous Bone Marrow Transplant Program Seattle Cancer Care Alliance Seattle, Washington
	Closing the Gap in Transfusion-Related Iron Overload Vasilios Berdoukas, MBBS Children’s Hospital Los Angeles Los Angeles, California
	Late Effects of Treatment for Childhood Cancer Smita Bhatia, MD, MPH Ruth Ziegler Chair in Population Sciences Co-leader, Cancer Control and Population Sciences Program Professor, Population Sciences Director, Outcomes Research Director, Center for Cancer Survivorship Staff Physician, Pediatrics City of Hope Duarte, California
	The Evolving Role of Maintenance Therapy after Hematopoietic Stem Cell Transplantation Michael R. Bishop, MD Professor of Medicine Director, Hematopoietic Stem Cell Transplantation Program The University of Chicago Medicine Chicago, Illinois
	Immunosuppression—New Options on the Horizon Kiran K. Dhanireddy, MD Assistant Professor of Surgery Director, Pancreas Transplantation Division of Hepatobiliary Surgery and Abdominal Organ Transplantation Keck School of Medicine University of Southern California Los Angeles, California
	Realizing the Promise of Precision Medicine for Certain Cancers John F. DiPersio, MD, PhD Deputy Director, Alvin J. Siteman Cancer Center Chief, Division of Oncology Virginia E. and Samuel J. Golman Endowed Professorship of Medicine, Pathology and Immunology Washington University School of Medicine St. Louis, Missouri
	Timely Referral of End-Stage Renal Disease Patients for Kidney Transplant Evaluation—Clinical and Financial Implications Abhinav Humar, MD Professor of Surgery Clinical Director, Thomas E. Starzl Transplantation Institute; Chief, Division of Transplantation Department of Surgery University of Pittsburgh Medical Center Pittsburgh, Pennsylvania
	Immunotherapy: Revolutionizing the Way We Treat Cancer Hatim Husain, MD Assistant Professor of Medicine UCSD Moores Cancer Center La Jolla, California
	Developing Better Treatments for Sickle Cell Disease Cage S. Johnson, MD Professor Emeritus of Medicine, Physiology and Biophysics Division of Hematology Director, Adult Sickle Cell Program Keck School of Medicine University of Southern California Los Angeles, California
	Update on Malignant Melanoma Karl Lewis, MD Associate Professor, Division of Medical Oncology School of Medicine University of Colorado Denver Denver, Colorado
	Intestinal Failure—Indications for Transplant Cal S. Matsumoto, MD Assistant Professor MedStar Georgetown Transplant Institute; Director, Small Bowel Transplantation Director, Center for Intestinal Care and Transplant MedStar Georgetown University Hospital Washington, DC
	Myelodysplastic Syndromes—What Is on the Horizon? Bruno Medeiros, MD Assistant Professor of Medicine (Hematology) Stanford University Medical Center Stanford, California
	Nursing Coordination in Patient Transition from the Transplant Team to the ICU Team Christina Mielke, MBA, PHN, RN Nurse Manager, Adult Blood and Marrow Transplant University of Minnesota Medical Center, Fairview Minneapolis, Minnesota
	Graft Versus Host Disease—New Strategy for Prevention Jeanne M. Palmer, MD Mayo Clinic Scottsdale, Arizona
	Islet-Cell Transplantation—The New Standard of Care Andrew Posselt, MD, PhD, FACS Associate Professor of Surgery Division of Transplant Surgery Director, Pancreatic Islet Cell Transplant Program University of California, San Francisco Medical Center San Francisco, California
	Baby Boomers and Hepatitis C John P. Roberts, MD Professor and Chief, Division of Transplant Surgery Chief, UCSF Medical Center Transplant Service Endowed Chair in Abdominal Transplantation University of California, San Francisco Medical Center San Francisco, California
	Biomarkers in Solid Organ Transplantation—A Personalized Approach Daniel R. Salomon, MD Professor Director, Laboratory for Functional Genomics Medical Program Director, Scripps Center for Organ and Cell Transplantation Department of Molecular and Experimental Medicine The Scripps Research Institute ® La Jolla, California
	Allogeneic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Alix E. Seif, MD, MPH Assistant Professor Perelman School of Medicine at the University of Pennsylvania; Attending Physician Blood and Marrow Transplantation Section Division of Oncology The Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
	Reduced-Intensity Transplantation for Hemoglobinopathy and Other Nonmalignant Disorders—The Pros and Cons Ami Shah, MD Professor of Pediatrics Pediatric Hematology Oncology Mattel Children's Hospital UCLA Health System Los Angeles, California
	The Role of Palliative Care in Pre- and Post-Stem Cell Transplantation Jacob J. Strand, MD Director of Symptom Management, Pain and Quality of Life Clinic Senior Associate Consultant Section of Palliative Medicine Division of General Internal Medicine Assistant Professor of Medicine Mayo Clinic College of Medicine Rochester, Minnesota
	Pediatric Heart Transplantation—A Multidisciplinary Approach Justin Yeh, MD Clinical Assistant Professor Pediatric Cardiology Lucile Packard Children's Hospital Palo Alto, California